Get started
Live feed
SECFilingvia Quantisnow
Sagimet Biosciences Inc. logo

SGMT: SEC Form 8-K filed by Sagimet Biosciences Inc.

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for SGMT

Across the 27 sessions after earlier SGMT headlines, the stock closed higher 15 times and lower 11 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

SGMT close-to-close change in the session after earlier headlines
SessionEarlier headlineSGMTSPY
Oct 22, 2026Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne-0.4%-1.2%
Oct 9, 2026Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference+0.1%+0.6%
Oct 2, 2026Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants-2.5%+0.7%
Sep 30, 2026Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrantsand 1 other headline that session+5.9%-0.2%
Sep 28, 2026Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026+7.6%-0.7%
Sep 24, 2026Goldman resumed coverage on Sagimet Biosciences with a new price target-12.6%-0.1%
Quantisnow market dataNASDAQ
Sagimet Biosciences Inc. logo
SGMT
Sagimet Biosciences Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2023
Get push alerts for SGMT

Follow SGMT and get a push notification the moment its next story breaks.

Full SGMT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGMT (Sagimet Biosciences Inc.) and more on Quantisnow.